News
LZAGY
61.12
-1.77%
-1.10
Weekly Report: what happened at LZAGY last week (0420-0424)?
Weekly Report · 2d ago
RBC Capital Reaffirms Their Buy Rating on Lonza Group Ltd (LONN)
TipRanks · 5d ago
Simulations Plus enters funded research collaboration with Lonza, FDA
TipRanks · 04/21 14:23
Barclays Reaffirms Their Buy Rating on Lonza Group Ltd (LONN)
TipRanks · 04/21 06:16
Weekly Report: what happened at LZAGY last week (0413-0417)?
Weekly Report · 04/20 09:12
Lonza price target lowered to CHF 630 from CHF 680 at Berenberg
TipRanks · 04/15 17:38
Berenberg Bank Issues a Buy Rating on Lonza Group Ltd (LONN)
TipRanks · 04/15 06:05
Berenberg Bank Remains a Buy on Lonza Group (LZAGY)
TipRanks · 04/15 05:27
Weekly Report: what happened at LZAGY last week (0406-0410)?
Weekly Report · 04/13 09:13
Weekly Report: what happened at LZAGY last week (0330-0403)?
Weekly Report · 04/06 09:13
Lonza: Structural Growth Intact, CHI Exit Strengthens Focus, Recent Weakness Reinforces Entry Opportunity
Seeking Alpha · 04/01 10:03
Weekly Report: what happened at LZAGY last week (0323-0327)?
Weekly Report · 03/30 09:13
Weekly Report: what happened at LZAGY last week (0316-0320)?
Weekly Report · 03/23 09:12
Most oversold healthcare stocks above $10B on Wall Street amid Middle East disruptions
Seeking Alpha · 03/16 14:47
Weekly Report: what happened at LZAGY last week (0309-0313)?
Weekly Report · 03/16 09:12
Kepler Capital Reaffirms Their Buy Rating on Lonza Group Ltd (LONN)
TipRanks · 03/11 01:48
Lonza Group Ltd (LONN) Gets a Buy from RBC Capital
TipRanks · 03/10 01:56
Weekly Report: what happened at LZAGY last week (0302-0306)?
Weekly Report · 03/09 09:12
Love A Little Risk? Wall Street Sees Massive Upside in Vaxcyte Stock.
Barchart · 03/02 14:28
Weekly Report: what happened at LZAGY last week (0223-0227)?
Weekly Report · 03/02 09:12
More
Webull provides a variety of real-time LZAGY stock news. You can receive the latest news about Lonza Gro through multiple platforms. This information may help you make smarter investment decisions.
About LZAGY
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.